Patent · US Active

Nanoparticulate fibrate formulations

US7931917B2 · kind B2 · utility

2Cited by

103References

30Claims

0Family size

Assignees

Elan Pharma International Ltd. · IE
Fournier Laboratories Ireland Limited · IE

Inventors

Tuula Ryde · Malvern, US
Evan Gustow · Villanova, US
Stephen B. Ruddy · Schwenksville, US
Rajeev Jain · Framingham, US
Rakesh Patel · Chicago, US
Michael John Wilkins · Midleton, IE

Key dates

Filing date	May 23, 2007
Grant date	Apr 26, 2011
Priority date	—
Expiry date	Feb 9, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/29
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.